Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 15/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | DTYMK | P23919 | 1/20 | 0.41 |
| ▸ | BRD4 | O60885 | 1/20 | 0.40 |
| ▸ | HTR6 | P50406 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1267232 | 1.00 | ELANE (0.46) | ELANEL3MBTL1POLBDTYMKBRD4 | |
| SCHEMBL30940044 | 0.90 | L3MBTL1 (0.47) | ELANEL3MBTL1POLBDTYMKBRD4 | |
| SCHEMBL3705482 | 0.90 | L3MBTL1 (0.47) | ELANEL3MBTL1POLBDTYMKBRD4 | |
| SCHEMBL4569771 | 0.90 | L3MBTL1 (0.50) | ELANEL3MBTL1POLBDTYMKBRD4 | |
| SCHEMBL4572234 | 0.87 | L3MBTL1 (0.46) | ELANEL3MBTL1POLBDTYMKBRD4 | |
| SCHEMBL3757166 | 0.85 | ELANE (0.43) | ELANEL3MBTL1POLBDTYMKBRD4 | |
| SCHEMBL3762275 | 0.85 | ELANE (0.47) | ELANEL3MBTL1POLBDTYMKBRD4 | |
| SCHEMBL4192135 | 0.84 | L3MBTL1 (0.54) | ELANEL3MBTL1POLBDTYMKBRD4 | |
| SCHEMBL30711710 | 0.83 | ELANE (0.55) | ELANEL3MBTL1POLBDTYMK | |
| SCHEMBL1457357 | 0.82 | HSP90AA1 (0.37) | ELANEL3MBTL1POLBBRD4HTR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4408845-A1 | NOVEL COMPOUNDS | Sitryx Therapeutics Limited (GB) | 2024-08-07 | — | — | EP | disclosed |
| WO-2023052783-A1 | NOVEL COMPOUNDS | SITRYX THERAPEUTICS LIMITED (GB) | 2023-04-06 | — | — | WO | disclosed |